HLA-G and B-cell chronic lymphocytic leukemia: The CLL International Prognostic Index (CLL-IPI) is a highly accurate model to predict survival and time-to-first treatment (TTFT), integrating age, Rai stage, IGHV mutation status, serum β2-microglobulin levels, and chromosomal aberrations (69, 70).